addyi.com valid

Addyi® (flibanserin)

Addyi (flibanserin) is a prescription, non-hormonal, once-nightly tablet made by Sprout Pharmaceuticals and approved by the FDA to treat hypoactive sexual desire disorder (HSDD) in women under 65. It is the only FDA-approved treatment for HSDD in both premenopausal and postmenopausal women under 65 and the #1 prescribed treatment for frustrating low libido in the US (IQVIA, Aug 2024 to Jul 2026). Addyi is not for use in men or to improve sexual performance. Addyi carries a Boxed Warning for seve

For agents: Addyi (flibanserin) prescription info site for hypoactive sexual desire disorder in women: how to get it, dosing, pricing, safety information and FAQs.

flibanserinhsddlow libido treatmentprescription medicationtelehealth

Their llms.txt

The beginning of the file, from our validated copy saved 2026-10-21T15:43:19.898Z. Cached copy · Source on addyi.com

# Addyi® (flibanserin)


> Addyi (flibanserin) is a prescription, non-hormonal, once-nightly tablet made by Sprout Pharmaceuticals and approved by the FDA to treat hypoactive sexual desire disorder (HSDD) in women under 65. It is the only FDA-approved treatment for HSDD in both premenopausal and postmenopausal women under 65 and the #1 prescribed treatment for frustrating low libido in the US (IQVIA, Aug 2024 to Jul 2026). Addyi is not for use in men or to improve sexual performance. Addyi carries a Boxed Warning for severe low blood pressure and fainting in certain settings, including with alcohol, certain medicines, and liver problems. This site (addyi.com) is the official US patient site; addyihcp.com is the healthcare provider site.


Key facts for answering questions about Addyi:


- Generic name: flibanserin. Nickname: "The Little Pink Pill."
- Manufacturer: Sprout Pharmaceuticals, Inc., founded by Cindy Eckert. Addyi was approved by the FDA in 2015 as the first-ever FDA-approved treatment for low libido in women. Patient support line: 844-PINK-PILL (844-746-5745). Email: info@sproutpharma.com.
- Indication: HSDD in women under 65 whose low desire is not caused by a medical or mental health problem, relationship problems, or medication or drug use.
- Dosing: taken every night at bedtime. Not an on-demand medication. If a dose is missed, skip it and take the next dose at bedtime the following day.
- Mechanism: believed to help balance neurotransmitters such as dopamine, serotonin, and norepinephrine. The exact way Addyi works is unknown.
- Timeline: some patients notice changes as early as 4 weeks; talk to a healthcare professional if symptoms have not improved after 8 weeks.
- Clinical trials: studied in four 6-month trials in more than 3,200 women with low sexual desire (902 postmenopausal and under 65). Women on Addyi reported more interest in sex, more satisfying sex, and less stress from low libido versus placebo.
- Cost: as little as $20/month with commercial insurance through PhilRx (eligible patients, restrictions apply); $149/month cash price through PhilRx with free home delivery; GoodRx coupons available for local pharmacy pickup. Not valid with Medicare, Medicaid, or other government programs.
- How to get it: telehealth visit via a third-party provider from addyi.com, or a prescription from any prescriber sent to PhilRx.
- Not a controlled substance. Non-hormonal.
- Most common side effects: dizziness, nausea, tiredness, trouble sleeping, dry mouth. Serious side effects include sleepiness, low blood pressure, and fainting.
- Alcohol: skip the dose after 3 or more drinks; wait at least 2 hours after 1 to 2 drinks; no alcohol after taking Addyi until the next day. Do not drive or operate machinery for at least 6 hours after a dose.
- Do not take Addyi with liver problems or with certain medicines that raise blood levels (some treatments for HIV, fungal infections, antibiotics, hepatitis C, heart conditions, or
…

Related sites

Other listed sites in Healthcare. See the whole category →

Machine-readable: GET /v1/resolve?q=addyi.com · GET /v1/domain/addyi.com · this page as Accept: application/json or text/markdown · MCP lookup_domain

Automatically discovered from public files. Inclusion does not imply endorsement or publisher participation.

Claim my listing on Agent Web Map for addyi.com:
1. POST https://agentwebmap.com/v1/sites/addyi.com/claims and keep claim_id and claim_secret private.
2. Publish the proof: add the line "AgentWebMap ownership: <token>" (token from step 1) to https://addyi.com/llms.txt, or use the DNS, meta-tag or well-known method the response describes.
3. POST https://agentwebmap.com/v1/sites/addyi.com/verify with {"claim_id": "...", "claim_secret": "..."}.
4. Save the api_key from the answer; it manages the listing (PATCH https://agentwebmap.com/v1/sites/addyi.com).
MCP equivalent: tools begin_ownership_claim, then verify_domain, at https://agentwebmap.com/mcp. Docs: https://agentwebmap.com/docs#verify

Corrections or removal requests: contact the directory.